DOI QR코드

DOI QR Code

Dosimetric and Clinical Predictors of Acute Esophagitis in Lung Cancer Patients in Turkey Treated with Radiotherapy

  • Etiz, Durmus (Department of Radiation Oncology, School of Medicine, Eskisehir Osmangazi University) ;
  • Bayman, Evrim (Department of Radiation Oncology, School of Medicine, Eskisehir Osmangazi University) ;
  • Akcay, Melek (Department of Radiation Oncology, School of Medicine, Eskisehir Osmangazi University) ;
  • Sahin, Bilgehan (Department of Radiation Oncology, School of Medicine, Eskisehir Osmangazi University) ;
  • Bal, Cengiz (Department of Biostatistics, School of Medicine, Eskisehir Osmangazi University)
  • Published : 2013.07.30

Abstract

Background: The purpose of this study was to determine the clinical and dosimetric factors associated with acute esophagitis (AE) in lung cancer patients treated with conformal radiotherapy (RT) in Turkey. Materials and Methods: In this retrospective review 104 lung cancer patients were examined. Esophagitis grades were verified weekly during treatment, and at 1 week, and 1 and 2 months afterwards. The clinical parameters included patient age, gender, tumor pathology, number of chemotherapy treatments before RT, concurrent chemotherapy, radiation dose, tumor response to RT, tumor localization, interruption of RT, weight loss, tumor and nodal stage and tumor volume. The following dosimetric parameters were analyzed for correlation of AE: The maximum ($D_{max}$) and mean ($D_{mean}$) doses delivered to the esophagus, the percentage of esophagus volume receiving ${\geq}10$ Gy ($V_{10}$), ${\geq}20$ Gy ($V_{20}$), ${\geq}30$ Gy ($V_{30}$), ${\geq}35$ Gy ($V_{35}$), ${\geq}40$ Gy ($V_{40}$), ${\geq}45$ Gy ($V_{45}$), ${\geq}50$ Gy ($V_{50}$) and ${\geq}60$ Gy ($V_{60}$). Results: Fifty-five patients (52.9%) developed AE. Maximum grades of AE were recorded: Grade 1 in 51 patients (49%), and Grade 2 in 4 patients (3.8%). Clinical factors had no statistically significant influence on the incidence of AE. In terms of dosimetric findings, correlation analyses demonstrated a significant association between AE and $D_{max}$ (>5117 cGy), $D_{mean}$ (>1487 cGy) and $V_{10-60}$ (percentage of volume receiving >10 to 60 Gy). The most significant relationship between RT and esophagitis were in $D_{max}$ (>5117 cGy) (p=0.002) and percentage of esophageal volume receiving >30 Gy ($V_{30}$ >31%) (p=0.008) in the logistic regression analysis. Conclusions: The maximum dose esophagus greater than 5117 cGy and approximately one third (31%) of the esophageal volume receiving >30 Gy was the most statistically significant predictive factor associated with esophagitis due to RT.

Keywords

Acute esophagitis;lung cancer;radiotherapy;side effect

References

  1. Ahn SJ, Kahn D, Zhou S, et al (2005). Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys, 61, 335-47. https://doi.org/10.1016/j.ijrobp.2004.06.014
  2. Bradley J, Deasy JO, Bentzen S, Naqa IE (2004). Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys, 58, 1106-13. https://doi.org/10.1016/j.ijrobp.2003.09.080
  3. Caglar HB, Othus M, Allen AM (2010). Esophagus in- field: a new predictor for esophagitis. Radiother Oncol, 97, 48-53. https://doi.org/10.1016/j.radonc.2010.07.024
  4. De Ruysscher D, Van Meerbeeck J, Vandecasteele K, et al (2012). Radiation-induced oesophagitis in lung cancer Patients : Is susceptibility for neutropenia a risk factor? Strahlenther Onkol, 188, 564-7. https://doi.org/10.1007/s00066-012-0098-z
  5. Dorr W, Hendry JH (2001). Consequential late effects in normal tissues. Radiother Oncol, 61, 223-31. https://doi.org/10.1016/S0167-8140(01)00429-7
  6. Emami B, Lyman J, Brown A et al (1991). Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 21, 109-22.
  7. Hirota S, Tsujino K, Hishikawa Y, et al (2001). Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother Oncol, 58, 273-8. https://doi.org/10.1016/S0167-8140(00)00274-7
  8. Huang EX, Bradley JD, Naga IE, et al (2012). Modeling the risk of radiation-Induced acute esophagitis for combined Washington University and RTOG Trial 93-11 lung cancer patients. Int J Radiat Oncol Biol Phys, 82, 1674-9. https://doi.org/10.1016/j.ijrobp.2011.02.052
  9. ICRU Report 62 (1999). International Commision on Radiation Units and Measurements:Prescribing, recording and reporting photon beam therapy, Bethesda.
  10. Lara PN Jr, Chansky K, Shibata T, et al (2010). Common arm comparative outcomes analysis of phase 3 trials of cisplatin+irinotecan versus cisplatin+etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124. Cancer, 116, 5710-5. https://doi.org/10.1002/cncr.25532
  11. Maguire P, Sibley G, Zhou SM, et al (1999). Clinical and dosimetric predictors of radiation-Induced esophageal toxicity. Int J Radiat Oncol Biol Phys, 45, 97-103. https://doi.org/10.1016/S0360-3016(99)00163-7
  12. Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M (2004). Predictors of acute esophagitis in patients with non small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys, 60, 1106-12. https://doi.org/10.1016/j.ijrobp.2004.04.051
  13. Qiao WB, Zhao YH, Zhao YB, Wang RZ (2005) Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity. World J Gastroenterol, 11, 2626-9. https://doi.org/10.3748/wjg.v11.i17.2626
  14. Rodriguez N, Algara M, Foro P, et al (2009). Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys, 73, 810-7. https://doi.org/10.1016/j.ijrobp.2008.04.064
  15. Rose J, Rodrigues G, Yaremko B, Lock M, D'Souza D (2009). Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol, 91, 282-7. https://doi.org/10.1016/j.radonc.2008.09.010
  16. Singh AK, Lockett MA, Bradley JD (2003). Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys, 55, 337-41. https://doi.org/10.1016/S0360-3016(02)03937-8
  17. Soo RA, Kawaguchi T, Loh M, et al (2012). Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy. Future Oncol, 8, 451-62. https://doi.org/10.2217/fon.12.25
  18. Takeda K, Nemoto K, Saito H, et al (2005). Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys, 62, 626-9. https://doi.org/10.1016/j.ijrobp.2005.04.004
  19. Werner-Wasik M, Scott C, Graham ML, et al (1999). Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. Int J Radiat Oncol Biol Phys, 44, 327-31. https://doi.org/10.1016/S0360-3016(99)00031-0
  20. Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curan W (2000). Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys, 48, 689-96. https://doi.org/10.1016/S0360-3016(00)00699-4
  21. Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks LB (2010). Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys ,76, 86. https://doi.org/10.1016/j.ijrobp.2009.05.070
  22. Court L, Wang J, Lin S (2012). SU-E-T-250:Dose-Response curves for the esophagus. Med Phys, 39, 3761.

Cited by

  1. Oral Glutamine Supplementation Reduces Radiotherapy-induced Esophagitis in Lung Cancer Patients vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.53
  2. Predictors for severe acute esophagitis in lung cancer patients treated with chemoradiotherapy: a systematic review vol.32, pp.10, 2016, https://doi.org/10.1080/03007995.2016.1205004